Accelerate Diagnostics Investor Relations Material
Latest events
Q3 2024
Accelerate Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Accelerate Diagnostics Inc
Access all reports
Accelerate Diagnostics Inc. is an in vitro diagnostics company specializing in rapid diagnostic solutions for infectious diseases. The company develops and markets systems and tests that enable the identification of pathogens and the determination of antimicrobial susceptibility directly from patient samples. Its flagship product, the Accelerate Pheno system, provides faster diagnostic results compared to traditional methods, helping healthcare providers optimize antimicrobial therapy and improve patient outcomes. The company is headquartered in Tucson, Arizona, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
AXDX
Country
🇺🇸 United States